LC-MS Analysis of Underivatized Bisphosphonate Drugs Using Mixed-Mode Reversed-Phase/Anion-Exchange Chromatography
Applications | 2025 | WatersInstrumentation
Bisphosphonates are widely prescribed for bone density disorders such as osteoporosis and Paget’s disease. Their strong polarity and acidic nature pose analytical challenges, traditionally addressed by derivatization to improve retention and detection. Developing a rapid LC-MS approach that bypasses derivatization simplifies workflows and enhances sensitivity in pharmaceutical and clinical laboratories.
This work aimed to establish a 6-minute mixed-mode reversed-phase/anion-exchange LC-MS method for four common underivatized bisphosphonate drugs. The study evaluated retention, separation efficiency, and method reproducibility using a novel column with high-performance surface technology.
The approach combined reversed-phase and anion-exchange interactions to retain highly polar analytes without chemical modification.
The mixed-mode column delivered clear retention and baseline separation of all four bisphosphonates within 6 minutes. High-performance surface (HPS) hardware significantly reduced nonspecific adsorption compared to stainless steel, yielding between 20 % and 100 % larger peak areas and improved precision (RSD < 3 % vs. up to 8 %). This enhancement eliminated lengthy column conditioning and minimized analyte–metal interactions, supporting reliable quantitation without derivatization or ion-pair reagents.
Advances may include tailored mixed-mode phases for designer bisphosphonates, integration with high-resolution mass spectrometry for complex biological matrices, and high-throughput screening in drug discovery. Further improvements in surface technologies could expand applications to other polar acidic compounds.
This study demonstrates a robust, high-throughput LC-MS method for underivatized bisphosphonates using mixed-mode RP/AX chromatography with high-performance surfaces. The method offers fast analysis, strong retention, and enhanced sensitivity, streamlining workflows in analytical and clinical laboratories.
LC/MS, LC/SQ
IndustriesPharma & Biopharma
ManufacturerWaters
Summary
Importance of the Topic
Bisphosphonates are widely prescribed for bone density disorders such as osteoporosis and Paget’s disease. Their strong polarity and acidic nature pose analytical challenges, traditionally addressed by derivatization to improve retention and detection. Developing a rapid LC-MS approach that bypasses derivatization simplifies workflows and enhances sensitivity in pharmaceutical and clinical laboratories.
Objectives and Study Overview
This work aimed to establish a 6-minute mixed-mode reversed-phase/anion-exchange LC-MS method for four common underivatized bisphosphonate drugs. The study evaluated retention, separation efficiency, and method reproducibility using a novel column with high-performance surface technology.
Methodology and Used Instrumentation
The approach combined reversed-phase and anion-exchange interactions to retain highly polar analytes without chemical modification.
- Sample preparation: Four bisphosphonate standards (1 mg/mL in 90:10 water:acetonitrile) combined into a mixed standard and stored at 4 °C in polypropylene vials.
- Chromatography: ACQUITY UPLC H-Class Plus System with HPS tubing; Atlantis Premier BEH C18 AX column (1.7 µm, 2.1 × 50 mm) at 40 °C; mobile phases: water (A), methanol (C), 200 mM ammonium formate pH 3 (D); flow rate 0.4 mL/min; injection volume 2 µL; gradient elution with 90:10 water:acetonitrile washes.
- Mass spectrometry: ACQUITY QDa Detector in negative ESI-SIR mode; capillary voltage 0.8 kV; cone voltage 15 V.
- Data analysis: Empower Chromatography Data System.
Main Results and Discussion
The mixed-mode column delivered clear retention and baseline separation of all four bisphosphonates within 6 minutes. High-performance surface (HPS) hardware significantly reduced nonspecific adsorption compared to stainless steel, yielding between 20 % and 100 % larger peak areas and improved precision (RSD < 3 % vs. up to 8 %). This enhancement eliminated lengthy column conditioning and minimized analyte–metal interactions, supporting reliable quantitation without derivatization or ion-pair reagents.
Benefits and Practical Applications
- Rapid analysis: Complete separation in under 6 minutes.
- No derivatization or ion-pair reagents needed, simplifying sample preparation and reducing cost.
- High sensitivity and reproducibility enabled by reduced adsorption.
- Compatibility with standard LC-MS platforms for pharmaceutical QA/QC and generic drug development.
Future Trends and Potential Applications
Advances may include tailored mixed-mode phases for designer bisphosphonates, integration with high-resolution mass spectrometry for complex biological matrices, and high-throughput screening in drug discovery. Further improvements in surface technologies could expand applications to other polar acidic compounds.
Conclusion
This study demonstrates a robust, high-throughput LC-MS method for underivatized bisphosphonates using mixed-mode RP/AX chromatography with high-performance surfaces. The method offers fast analysis, strong retention, and enhanced sensitivity, streamlining workflows in analytical and clinical laboratories.
Reference
- Graham R, Russell G. Bisphosphonates: The first 40 years. Bone. 2011;49(1):2–19.
- Chen M, Liu K, Zhong D, Chen X. Trimethylsilyldiazomethane derivatization coupled with solid-phase extraction for the determination of alendronate in human plasma by LC-MS/MS. Anal Bioanal Chem. 2012;402(2):791–798.
- Popov K, Oshchepkov M, Tkachenko S, Sergienko V, Oshchepkov A. Bisphosphonates: Synthesis, structures, properties, medical and industrial applications. J Mol Liq. 2022;351:118619.
- Walter TH, Alden BA, Field JA, et al. Characterization of a highly stable mixed-mode reversed-phase/weak anion-exchange stationary phase. J Sep Sci. 2021;44(5):1005–1014.
- Meng X, Zhenwei W. A mixed-mode reversed-phase/strong-anion-exchange stationary phase: Application in analysis of NSAIDs. J Chromatogr A. 2024;1722:464871.
- DeLano M, Walter TH, Lauber MA, et al. Using hybrid organic-inorganic surface technology to mitigate analyte interactions with metal surfaces in UHPLC. Anal Chem. 2021;93:5773–5781.
- Berthelette KD, DeLoffi M, Collins C, et al. Correlation between the adsorption of acidic analytes on stainless steel columns and their ionic charge. Waters Application Note 720008792. 2025.
- Smith K, Wilson I, Rainville P. Mass spectrometry-compatible RP-UHPLC analysis of tricarboxylic acid cycle and related metabolites in human urine. Anal Chem. 2021;93:1009–1015.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Analysis of Underivatized Bisphosphonate Drugs Using HILIC-MS
2025|Waters|Applications
Application Note Analysis of Underivatized Bisphosphonate Drugs Using HILIC-MS Kenneth Berthelette, Melissa Aiello, Chris Collins, Thomas H. Walter Waters Corporation, United States Published on June 04, 2025 Contact Sales Abstract Bisphosphonate drugs are an important class of therapeutics used for…
Key words
bisphosphonate, bisphosphonatehilic, hilicunderivatized, underivatizeddrugs, drugspremier, premierbeh, behatlantis, atlantisusing, usinganalysis, analysiscolumn, columnacquity, acquityshape, shapeprivacy, privacyretention, retentionpda
Analysis of Radioligand Therapy Components Using Reversed-Phase and HILIC Columns
2025|Waters|Applications
Application Note Analysis of Radioligand Therapy Components Using Reversed-Phase and HILIC Columns Kenneth D. Berthelette, Melissa Aiello, Christopher Collins, Jamie Kalwood, Thomas H. Walter Waters Corporation Abstract Radiotherapy techniques have evolved over the years. While traditional radiotherapy is still used…
Key words
radioligand, radioligandtherapy, therapyhilic, hilicreversed, reversedcolumns, columnscomponents, componentsphase, phaseusing, usinganalysis, analysissirs, sirspremier, premierchelator, chelatorstainless, stainlesssteel, steelacquity
Utilization of MaxPeak High Performance Surfaces and the Atlantis PREMIER BEH C18 AX Column to Increase Sensitivity of LC-MS Analysis
2020|Waters|Technical notes
[ TECHNOLOGY BRIEF ] Utilization of MaxPeak High Performance Surfaces and the Atlantis PREMIER BEH C18 AX Column to Increase Sensitivity of LC-MS Analysis Kerri M. Smith and Paul Rainville Waters Corporation, Milford, MA, USA MaxPeak High Performance Surfaces (HPS)…
Key words
maxpeak, maxpeakhps, hpsatlantis, atlantisanalyte, analytesurface, surfaceinteractions, interactionsbicalutamide, bicalutamidepremier, premierminimizing, minimizingbrief, briefdiazoxide, diazoxideinnocuous, innocuousdesigned, designedsurfaces, surfacesinnovative
IMPROVED PERFORMANCE OF MODERN MS-COMPATIBLE REVERSED-PHASE/ANION-EXCHANGE MIXED-MODE HPLC COLUMNS
2020|Waters|Posters
IMPROVED PERFORMANCE OF MODERN MS-COMPATIBLE REVERSED-PHASE/ANION-EXCHANGE MIXED-MODE HPLC COLUMNS Thomas H. Walter, Bonnie A. Alden, Melvin Blaze, Cheryl Boissel, Donna Osterman, Amit V. Patel, Mathew DeLano, Nicole Lawrence, Jessica Field, Moon Chul Jung, Waters Corporation, 34 Maple Street, Milford, MA…
Key words
brand, brandeffect, effectinfusions, infusionsmatrix, matriximproved, improvedbonded, bondedbleed, bleedunion, unioncolumn, columnhardware, hardwareanalytes, analytesphase, phasebeh, behflowof, flowofformicesi